Lunning, M. A., Omofuma, O. O., Li, M., Hampp, C., Phelan, M., Breskin, A., Shao, P., Hearnden, C., Shariff, S., Mukherjee, N., Ambati, S. R., Mohamed, H., Chaudhry, A., Suvannasankha, A. (2025). Second primary malignancy in patients with diffuse large B-cell lymphoma (DLBCL) receiving chimeric antigen receptor T-cell (CAR T) therapy and other systemic anti-cancer therapy: A real-world data analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.7080